Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis

Diabetes/Metabolism Research and Reviews

Volumn 17, Issue 1, 2001, Pages 27-43

  Tomkin, Gerald H ^a,b   Owens, Daphne ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b NONE   (Ireland)

Author keywords

Apo B lipoproteins; Atherosclerosis; Diabetes; Endothelium; Macrophages

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; CHYLOMICRON; FATTY ACID; LOW DENSITY LIPOPROTEIN; PROTEIN PRECURSOR; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CAUSE OF DEATH; CLEARANCE; DIABETES MELLITUS; DIET; ENDOTHELIUM; HUMAN; INTESTINE; LIPID COMPOSITION; LIPOPROTEIN SECRETION; LIVER FUNCTION; MACROPHAGE; MEDICAL LITERATURE; OXIDATION; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; REVIEW;

APOLIPOPROTEINS B; ARTERIOSCLEROSIS; CHYLOMICRONS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; REFERENCE VALUES;

EID: 0035098429     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.179     Document Type: Review

References (181)

1. Review of alterations in endothelial nitric oxide production in diabetes. Protective role of arginine on endothelial dysfunction
2. The effect of diabetes mellitus on sterol synthesis in the diabetic rat
3. Diabetes increases hepatic hydroxymethyl glutaryl coenzyme A reductase protein and mRNA levels in the small intestine
4. Cholesterol metabolism in the alloxan-diabetic rabbit
5. Serum lipoproteins and cholesterol metabolism in two hypercholesterolaemic rabbit models
6. Comparative study of the rate-limiting enzymes of cholesterol synthesis, esterification and catabolism in the alloxan-induced diabetic rat and rabbit
7. The relationship between cholesterol absorption and intestinal cholesterol synthesis in the diabetic rat model
8. Cholesterol absorption, synthesis and LDL metabolism in NIDDM
9. Increased intestinal glucose absorption and postprandial hyperglycaemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima fatty rats
10. Effect of diabetes on intestinal growth and hexose transport in the rat
11. Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms
12. Effects of ingested fat on fatty acid composition of serum lipoproteins
13. Assembly and secretion of chylomicrons in differentiated Caco-2 cells: Nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly
14. Influence of diets rich in saturated and w-6- polyunsaturated fatty acids on the postprandial response of apolipoproteins B48, B100, E and lipids in triglyceride-rich lipoproteins
15. Effect of the fat composition of a single meal on the composition and cytotoxicity potencies of lipolytically-releasable free fatty acids in post-prandial plasma
16. Increased J774 macrophage cytotoxicity of late postprandial triglyceride-rich lipoproteins from normolipaemic young men expressing apolipoprotein E4 allele
17. Dietary unsaturated fatty acids in type 2 diabetes: Higher levels of atherogenic postprandial lipoproteins on a linoleic compared to an oleic acid-rich diet
18. Postprandial lipoproteins and the progression of coronary atherosclerosis
19. The role of dietary cholesterol in the regulation of post-prandial apolipoprotein B48 levels in diabetes
20. Postprandial vitamin A metabolism in humans: A reassessment of the use of plasma retinyl esters as markers for intestinally-derived lipoproteins and their remnants
21. A stable isotope method using [2H5] glycerol bolus to measure very low density lipoprotein triglyceride kinetics in humans
22. Detection, quantification and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins
23. Improved metabolic control reduces the number of postprandial apolipoprotein B48-containing particles in Type 2 diabetes
24. Quantification of apo B48 in triglycerol-rich lipoproteins by specific enzyme-linked immunosorbent assay
25. Lack of influence of test meal fatty acid composition on the contribution of intestinally-derived lipoproteins to postprandial lipaemia
26. Determination of apo B48 and B100 in triglyceride-rich lipoproteins by sodium dodecyl sulphate polyacrylamide gel electrophoresis
27. Plasma apoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal
28. Separation and determination of remnant-like particles in human serum using monoclonal anti apo B100 and anti apo A1
29. Measurement of apolipoprotein B concentration in plasma lipoproteins by combining selective precipitation and mass spectrometry
30. Isolated rabbit enterocytes as a model cell system for investigation of chylomicron assembly and secretion
31. Intercellular mechanisms regulating apo B-containing lipoprotein assembly in primary hamster hepatocytes
32. Increased dietary triacylglycerol markedly enhances the ability of isolated rabbit enterocytes to secrete chylomicrons: An effect related to dietary fatty acid composition
33. The Role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes
34. The role of diabetes in delayed chylomicron clearance
35. Postprandial hyperlipidaemia in streptozotocin-induced diabetic rats is due to abnormal increase in intestinal acyl coenzyme A: Cholesterol acyltransferase activity
36. Acylcoenzyme A: Cholesterol acyltransferase
37. Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocyte-macrophages
38. Novel effects of the acylcoenzyme A: Cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages
39. Inhibition of hepatic ACAT decreases apo B secretion in miniature pigs fed a cholesterol-free diet
40. Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous Xanthomatosis in mice with congenital hyperlipidaemia
41. All apo B-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified
42. ACAT inhibition decreases LDL cholesterol in rabbits fed a cholesterol-free diet: Marked changes in LDL cholesterol without changes in LDL receptor mRNA abundance
43. A proposed model for assembly of chylomicrons
44. Inhibition of the microsomal triglyceride transfer protein blocks the first step of apolipoprotein B lipoprotein assembly but not the addition of bulk core lipids in the second step
45. Increased microsomal triglyceride transfer protein in diabetic rabbits. The cause of elevated postprandial apo B48-containing chylomicrons?
46. Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase
47. Human apolipoprotein E. Determination of the heparin binding sites of apo E3
48. Apolipoprotein E: Structure-function relationships
49. Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to subendothelial matrix
50. Overexpression of apolipoprotein E prevents development of diabetic hyperlipidaemia in transgenic mice
51. Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidaemia by stimulating hepatic VLDL production and impairing VLDL lipolysis
52. Overexpression and accumulation of apo E as a cause of hypertriglyceridaemia
53. Association of apolipoprotein (apo) E genotype with apo E levels
54. Effects of apo E genotype on apo B48 and apo B100 kinetics with stable isotopes in humans
55. Combined effects of lipoprotein lipase and apo E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort
56. Enrichment with apolipoprotein E characterises postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: A preliminary report
57. Effect of dietary cholesterol and alloxan-diabetes on tissue cholesterol and apolipoprotein E mRNA levels in the rabbit
58. Determination of the lower threshold of apolipoprotein E resulting in remnant lipoprotein clearance
59. Remnant lipoprotein metabolism: Key pathways involving cell-surface heparin sulfate proteoglycans and apolipoprotein E
60. Delayed catalism of apo B48 lipoproteins due to decreased heparin sulphate proteoglycan production in diabetic mice
61. Overexpression of human apolipoprotein C111 in transgenic mice results in accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E
62. Transcriptional regulation of the apo C111 gene by insulin in diabetic mice: Correlation with changes in plasma triglyceride levels
63. Accumulation of apolipoprotein C-1-rich cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridaemia in normolipidaemic patients with coronary artery disease
64. Diabetes and the Mediterranean diet: A beneficial effect of oleic acid on insulin sensitivity, adipocyte glucose transport and endothelium dependent vasoreactivity
65. Effect of a diet rich in monounsaturated fatty acids on the apolipoproteins involved in the clearance of postprandial lipoproteins in type 2 diabetic patients
66. Tissue specific regulation of lipoprotein lipase activity by insulin/glucose in normal weight humans
67. Improved glycaemic control in type 2 diabetes: Effect of metformin on postprandial lipoproteins
68. Method to measure apolipoprotein B48 and B100 secretion rates in an individual mouse: Evidence for a very rapid turnover of VLDL and preferential removal of B48 relative to B100-containing lipoproteins
69. Increased expression of apo lipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma
70. Insulin and nonesterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men
71. Postprandial hypertriglyceridaemia and insulin resistance in normoglycaemic first-degree relatives of patients with type 2 diabetes
72. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM
73. Overproduction of small very low density lipoproteins (sf 20-60) on moderate hypercholesterolaemia: Relationship between apolipoprotein B kinetics and plasma lipoproteins
74. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway
75. Effect of heparin-stimulated plasma lipolytic activity on VLDL apo B subclass metabolism in normal subjects
76. Microsomal triglyceride transfer protein
77. Adenovirus-mediated overexpression of microsomal triglyceride transfer protein (MTP): Mechanistic studies on the role of MTP in apolipoprotein B100 biogenesis
78. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice
79. The assembly of triacylglycerol-rich lipoproteins: An essential role for the microsomal triacylglycerol transfer protein
80. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglyceride and apolipoprotein B
81. Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: Insulin negatively regulates MTP gene expression
82. Increased microsomal triglyceride transfer protein (MTP) expression in the intestine but not the liver of diabetic rabbits
83. Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs
84. Long-term regulation of lypolysis and hormone sensitive lipase by insulin and glucose
85. Acute hyperinsulinaemia decreases the hepatic secretion of very low density lipoprotein apolipoprotein B100 in NIDDM
86. Increased hepatic secretion of very low density lipoprotein apolipoprotein B100 in NIDDM
87. Significant improvement in apo B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus
88. Effect of acute hyperinsulinaemia on VLDL triglyceride and VLDL apo B production in normal weight and obese individuals
89. Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects
90. The role of the LDL receptor in apolipoprotein B secretion
91. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice
92. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins
93. Hepatic triglyceride lipase promotes low density lipoprotein receptor-mediated catabolism of very low density lipoproteins in vitro
94. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein
95. Plasma kinetics of apoC111 and apoE in normolipaemic and hypertriglyceridaemic subjects
96. Apo E structure determines VLDL clearance and atherosclerosis risk in mice
97. Apolipoprotein C111 displacement of apolipoprotein E from VLDL; effect of particle size
98. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions; relative contribution of small dense LDL to coronary heart disease risk
99. Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism
100. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions
101. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: A stable isotope kinetic study
102. Post-prandial apolipoprotein B48 and B100-containing lipoproteins in Type 2 diabetes: Do statins have a specific effect on triglyceride metabolism?
103. Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death
104. Beyond Cholesterol: Modifications of LDL which increase its atherogenicity
105. Autooxidation of human low density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes
106. Oxidation of low density lipoprotein in non-insulin dependent diabetes: Its relationship to fatty acid composition
107. Lipoprotein composition in NIDDM. The effect of dietary oleic acid on composition and oxidisability and function of low and high density lipoproteins
108. The relationship between low density lipoprotein fatty acid composition and size in diabetes
109. Lipoprotein glycation and its metabolic consequences
110. Glycosylated low density lipoprotein is more sensitive to oxidation: Implications for the diabetic patient
111. Is glycation of low density lipoproteins in type 2 diabetic patients a pre-oxidative condition?
112. Sialic acid content of low density lipoprotein and its relation to lipid concentrations and metabolism of low density lipoprotein cholesterol
113. Autoantibody against oxidised LDL and the progression of atherosclerosis
114. Atherosclerosis - An inflammatory disease
115. Antibodies to oxidised lipoproteins: The relationship to myocardial infarction
116. Autoantibodies to oxidised LDL are related to LDL fatty acid composition in diabetes
117. Rabbit and human atherosclerotic lesions contain IgG that recognises epitopes of oxidised LDL
118. Oxidised-containing immune complexes induce Fc gamma receptor 1-mediated mitogen-activated protein kinase activation in THP-1 macrophages
119. Activation of human monocyte-derived macrophage immune complexes containing low density lipoprotein
120. Transcriptional and pre-transcriptional regulation of LDL receptor gene expression in PMA-treated THP-1 cells by LDL containing immune complexes
121. The uptake of LDL-IC by human macrophages: Predominant involvement of the Fc gamma R1 receptor
122. Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary disease risk
123. Change in LDL particle size is associated with change in plasma triglyceride concentration
124. Regulation of low density lipoprotein particle size and distribution in NIDDM and coronary artery disease: Importance of serum triglycerides
125. Optimisation of glycaemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients
126. Low density lipoprotein particle size and risk factors of insulin resistance syndrome
127. Antibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass B pattern
128. The influence of low density lipoprotein composition on its metabolism in non-insulin-dependent diabetes mellitus
129. Cholesterol-lowering with simvastatin improves prognosis of diabetic patients with heart disease
130. The effect of different dietary fatty acids on lipoprotein metabolism: Concentration-dependent effects of diets enriched in oleic, myristic, palmitic and stearic acids
131. Dietary fatty acids and the regulation of plasma low density lipoprotein cholesterol concentrations
132. Dietary mono-unsaturated fatty acids alter low density lipoprotein composition and function in Type 2 diabetes mellitus
133. Triglyceride as a risk factor for coronary artery disease
134. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
135. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality on subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective study
136. Alterations in apolipoprotein B-48 in the post-prandial state
137. Elevated triglyceride-rich lipoproteins in diabetes: A study of apolipoprotein B48
138. Intestinally-derived lipoprotein particles in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia
139. Role of cholesterol ester mass in regulation of secretion of apo B100 lipoprotein particles by hamster hepatocytes and effects of statins on that relationship
140. Atherogenesis: A postprandial phenomenon
141. Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins
142. Retention of fluorescent-labeled chylomicron remnants within the intima of the arterial wall - Evidence that plaque cholesterol may be derived from post-prandial lipoproteins
143. Retention of chylomicron remnants by arterial tissue: Importance of an efficient clearance mechanism from plasma
144. Apolipoprotein B48 or its apolipoprotein B100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor
145. Antipeptide antibodies reveal interrelationships of MBP 200 and MBP 235: Unique apo B-specific receptors for triglyceride-rich lipoproteins on human monocyte-macrophages
146. Hypertriglyceridaemic VLDL decreases plasminogen binding to endothelial cells and surface localised fibrinolysis
147. Genotype-specific transcriptional regulation of PAI-1expression by hypertriglyceridaemic VLDL and Lp(a) in cultured human endothelial cells
148. VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: Involvement of the VLDL receptor
149. The influence of chyclomicron remnants on endothelial function in the isolated perfused rat aorta
150. Remnants of chylomicrons and very low density lipoprotein impair endothelium-dependent vasorelaxation
151. Membrane active lipids in remnant lipoproteins cause impairment of endothelium-dependent vasorelaxation
152. A Macrophage receptor for apo B48: Cloning, expression and atherosclerosis
153. Macrophages, diabetes and atherosclerosis
154. Uptake of type 1V hyperlipidaemic VLDL by cultured macrophages is enhanced by interferon gamma
155. Relative importance of the LDL receptor and scavenger receptor class B in the beta VLDL-induced uptake and accumulation of cholesteryl esters by peritoneal macrophages
156. Specific interaction of oxidised low density lipoprotein with macrophage-derived foam cells isolated from rabbit atherosclerotic lesions
157. CD3, a novel receptor for oxidised low density lipoproteins, is highly expressed on lipid-laden macrophages in human aorta
158. Oxidised LDL- Induced NF-κB activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients
159. Oxidised low density lipoprotein suppresses expression of inducible cyclooxigenase in human macrophages
160. Chlamydial heat shock protein 60 localises in human atheroma and regulates macrophage tumor necrosis factor alpha and matrix metalloproteinase expression
161. Effects of low density and high density lipoproteins isolated from non-insulin dependent patients on prostaglandin secretion by mouse macrophage cell line P388D1
162. All apo B-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase
163. Oxidised LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells
164. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease
165. Oxidised low density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression
166. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance
167. Alimentary lipaemia in men with myocardial infarction at a young age
168. Ciprofibrate therapy improves endothelial function and reduces postprandial lipaemia and oxidative stress in Type 2 diabetes mellitus
169. The Yin and Yang of oxidation in the development of the fatty streak
170. Immunodepletion experiments suggest that acyl-coenzyme A: Cholesterol acyl-transferase-1 (ACAT-1) protein plays a major catalytic role in adult human liver, adrenal gland, macrophages and kidney but not in intestines
171. Chemokine receptor CCR2 expression and monocyte chemo-attractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL
172. Expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxisdised low density lipoproteins
173. Elevated concentrations of soluble e-selectin and vascular cell adhesion molecule-1 in NIDDM
174. Low density lipoprotein augments interleukin-1 induced vascular adhesion molecule expression in human endothelial cells
175. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis
176. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator activated receptor gamma activators
177. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoproteins
178. Inactivation of endothelial derived relaxing factor by oxidised lipoproteins
179. Effects of native and oxidised low density lipoproteins on the formation and inactivation of EDRF
180. Glyc-oxidised LDL impair endothelial function more potently than oxidised LDL: Role of enhanced oxidative stress
181. Mortality from coronary heart disease in diabetic subjects with type 2 diabetes and in non diabetic subjects with and without prior myocardial infarction